Working… Menu

Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00761449
Recruitment Status : Completed
First Posted : September 29, 2008
Last Update Posted : April 27, 2012
Information provided by (Responsible Party):
Nordic MDS Group